Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

U.S. Legislative Update: Takeaways for European Pharma (European Pharmaceutical Review)

Related Content

PTAB’s Reversal Sheds Light on Quantum Computing Patents

Four Steps to Maximize the Value of AI Innovation in Medtech

Five Steps Hotel Owners, Operators, and Management Companies Can Take to Mitigate Risk in the Face of Heightened Antitrust Scrutiny and a Wave of Lawsuits Involving Revenue-Management Tools

Life Sciences Licensing and M&A Update: Catching Up on Recent Decisions Affecting Commercially Reasonable Efforts Definitions and Post-Patent Expiration Royalty Obligations

The Rapid Rise of AI, in Five Charts

U.S. Supreme Court Significantly Curtails SEC Enforcement Forum Discretion

JAMS Release Mass Arbitration Procedures Following AAA’s Lead

Lawsuit Filed Challenging FDA Final Rule Regulating Laboratory Developed Tests

2025 FDLI Annual Conference

Six Goodwin Lawyers Named to Law360’s 2025 Editorial Advisory Boards

2seventy bio To Be Acquired by Bristol Myers Squibb for $5.00 per Share

Chambers Global 2025 Recognizes Goodwin Lawyers and Practices as Worldwide Leaders

Gabriela Morales-Rivera and Kevin DeJong Honored by Massachusetts Lawyers Weekly Excellence in the Law Awards

Goodwin Succeeds in Obtaining Dismissal of Attorney General Lawsuit Against the Town of Milton at the Massachusetts Supreme Judicial Court

Novo Holdings Completes $16.5 Billion Acquisition of Catalent

Goodwin Secures $452 Million Trade Secret Award for Insulet Corporation, One of The Largest Trade Secret Jury Awards in the Last Five Years

Life Sciences

Litigation

Intellectual Property